The relartionship of serum Antimullerian Hormone and arteriosclerosis in women with Polycystic Ovarian Syndrome.

The relartionship of serum Antimullerian Hormone and arteriosclerosis in women with Polycystic Ovarian Syndrome. - The relartionship of serum Antimullerian Hormone and arteriosclerosis in women with Polycystic Ovarian Syndrome.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027426

Enrollment

Registered

2019-06-27

Start date

2017-06-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polysistic ovary

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: a

Exclusion criteria

Exclusion criteria: a

Design outcomes

Primary

Measure	Time frame
a	—

Countries

Japan

Contacts

Public ContactAi Sakamoto

Okayama University Graduate School of Medicine, Density and Pharmaceutical Sciences. Department of Obstetrics and Gynecology

aisakamoto@cc.okayama-u.ac.jp086-235-7320

Outcome results